phase readout
saveNCT07455825: A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years
COMPLETEDupdated 2m ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants
view source ↗
comments(0)
5-min edit window · permanent after that